Promedix
ProMedix Inc is dedicated to revolutionizing circulatory dysfunction monitoring through innovative, noninvasive technology. Their mission is to provide reliable, accurate, and rapid assessment tools for early detection and management of conditions like sepsis, dehydration, and hemorrhage, ultimately improving patient outcomes and supporting clinical decision-making.
Industries
Nr. of Employees
small (1-50)
Promedix
1234 Innovation Drive, Portland, OR 97201
Patents
Products
Digital capillary refill time (CRT) monitor
A handheld, noninvasive CRT detector that integrates optical, pressure, and temperature sensors with a mobile app to perform guided measurements, compute objective CRT values in real time, and store raw data and results in a secure cloud.
Digital capillary refill time (CRT) monitor
A handheld, noninvasive CRT detector that integrates optical, pressure, and temperature sensors with a mobile app to perform guided measurements, compute objective CRT values in real time, and store raw data and results in a secure cloud.
Services
Design and execution of IRB-approved observational and prospective clinical studies to evaluate device performance, including multi-site patient encounters and data collection for peer-reviewed publication.
Design and execution of IRB-approved observational and prospective clinical studies to evaluate device performance, including multi-site patient encounters and data collection for peer-reviewed publication.
Expertise Areas
- Point-of-care circulatory monitoring
- Clinical study design and execution (IRB-approved observational and prospective trials)
- Biosignal acquisition and waveform analysis
- Signal-processing for physiological measurements
Key Technologies
- Optical photoplethysmographic sensing
- Pressure sensors for standardized compression
- Temperature sensors for signal quality assessment
- Sigma-delta analog-to-digital conversion (high-resolution ADC)
News & Updates
ProMedix awarded $255,000 Phase 1 STTR grant from NSF
ProMedix received a nondilutive grant from the National Science Foundation to support ongoing R&D and technology improvements.
ProMedix completes FDA q-sub meeting and receives guidance on 510(k) clearance
After meetings with regulators, ProMedix completes a q-sub meeting with FDA and receives guidance on next steps for design validation and safety testing.
ProMedix selected for Creative Destruction Lab (CDL) in Vancouver
ProMedix was chosen to participate in CDL-Vancouver, a global startup program focusing on health tech convergence.
ProMedix receives additional capital from Baxter’s Innovation Fund and Edward Elmhurst Driven Healthcare Ventures
The company was selected to receive further investment from these venture funds.
ProMedix publishes research on device accuracy and skin tone validation
Research articles in reputable journals demonstrate the device's accuracy and reliability across diverse patient populations.
ProMedix awarded $100,000 Business Oregon Innovation Grant
The company received a competitive innovation grant to support its development.
ProMedix awarded $255,000 Phase 1 STTR grant from NSF
ProMedix received a nondilutive grant from the National Science Foundation to support ongoing R&D and technology improvements.
ProMedix completes FDA q-sub meeting and receives guidance on 510(k) clearance
After meetings with regulators, ProMedix completes a q-sub meeting with FDA and receives guidance on next steps for design validation and safety testing.
ProMedix selected for Creative Destruction Lab (CDL) in Vancouver
ProMedix was chosen to participate in CDL-Vancouver, a global startup program focusing on health tech convergence.
ProMedix receives additional capital from Baxter’s Innovation Fund and Edward Elmhurst Driven Healthcare Ventures
The company was selected to receive further investment from these venture funds.
ProMedix publishes research on device accuracy and skin tone validation
Research articles in reputable journals demonstrate the device's accuracy and reliability across diverse patient populations.
ProMedix awarded $100,000 Business Oregon Innovation Grant
The company received a competitive innovation grant to support its development.